GCG and Obesity: Despite an ever-increasing abundance of weight management programs and products attempting to reduce obesity, substantial, and long-term weight loss has not been achieved, with the exception of pharmacotherapy including glucagon-like peptide-1 (GLP-1) analogs (4, 5) or more drastic measures such as surgery among the extremely obese in general or those with associated comorbidities such as diabetes (6).